Skip to main content

National Institutes of Health

Sharing New Research on Vaccinology

Leading global experts will share cutting-edge research on addressing vaccine hesitancy and new vaccines to prevent Zika, dengue, influenza, and antimicrobial resistance in Baltimore at the NFID 2019 Annual Conference on Vaccinology Research…

Developing Improved Vaccines for Older Adults

By 2030, the number of adults age 65 years and older in the United States is expected to grow to 71 million—at least 20 percent of the total population. It is particularly important during this stage of life to maintain healthy lifestyles and habits. Receiving recommended immunizations is an essential part of that process.,,

The Future of Influenza Vaccines

Creating transformational influenza vaccines that would eliminate seasonal influenza outbreaks, and decrease the threat of pandemic influenza is hard work. While we have made progress, there is much more to be done. Continued funding for influenza research is critical for protecting the health of the US population.

Vaccine Lessons Learned in Three Short Stories

Special thanks to Kathryn M. Edwards, MD, Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics and Director, Vanderbilt Vaccine Research Program at Vanderbilt University School of Medicine for sharing her acceptance speech for the 2016 Dr. Charles Mérieux Award for Achievement in Vaccinology and Immunology, delivered by William Schaffner, MD at the 2016 NFID Annual Conference on Vaccine Research.